Recent

% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • arthurs1 arthurs1 May 29, 2013 5:01 PM Flag

    ISIS drug will prove to be better, has fewer limitations, drug interactions etc etc

    2013 NATIONAL LIPID ASSOCIATION ANNUAL SCIENTIFIC SESSIONS
    MAY 30-JUNE 2, 2013
    LAS VEGAS, NV
    Session Type Poster Presentation
    Session Title Pharmacological Control of Lipids and Lipoproteins
    Dates and Times Friday, May 31, 2013 – 1:00 p.m. to 2:00 p.m. PT
    Saturday, June 1, 2013 – 12:30 p.m. to 1:30 p.m. PT
    Poster Number 167
    Presentation Title
    LONG TERM EFFICACY AND SAFETY OF MIPOMERSEN
    DURING 4 YEARS OF TREATMENT IN A COHORT OF
    PATIENTS WITH HETEROZYGOUS FAMILIAL
    HYPERCHOLESTEROLEMIA AND CORONARY ARTERY
    DISEASE (CAD)
    Duell PB1, Rose JE1, Selvey S2, Alam S2, Mittleman RS2
    1Oregon Health & Science University, Portland, OR 2Genzyme, a Sanofi
    Company, Cambridge, MA
    Session Type Poster Presentation
    Session Title Pharmacological Control of Lipids and Lipoproteins
    Dates and Times Friday, May 31, 2013 – 1:00 p.m. to 2:00 p.m. PT
    Saturday, June 1, 2013 – 12:30 p.m. to 1:30 p.m. PT
    Poster Number 168
    Presentation Title
    LACK OF DRUG-DRUG INTERACTION BETWEEN
    MIPOMERSEN AND WARFARIN IN HEALTHY VOLUNTEER

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AEGR
17.69+0.03(+0.17%)Aug 31 4:00 PMEDT